Notes: AT-001 is an inhibitor of aldose reductase (IC50 = 28.9 pM).{64353} It reduces infarct area in streptozotocin-induced diabetic mice expressing human aldose reductase in a model of cardiomyopathy induced by ischemia-reperfusion injury when administered at a dose of 40 mg/kg.{64354}